Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Simon Chowdhury, David F. McDermott, Martin Henner Voss, Robert E. Hawkins, Paola Aimone, Maurizio Voi, Naëije Isabelle, Yi Wu, Jeffrey R. Infante; Sarah Cannon | ||||||||||||
Title | A phase I/II study to assess the safety and efficacy of pazopanib (PAZ) and pembrolizumab (PEM) in patients (pts) with advanced renal cell carcinoma (aRCC). | ||||||||||||
|
|||||||||||||
URL | http://meetinglibrary.asco.org/record/152938/abstract | ||||||||||||
Abstract Text | J Clin Oncol 35, 2017 (suppl; abstr 4506) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|